AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/23/2024 | Press release | Distributed by Public on 05/23/2024 05:04
Please select the service you want to use:
Smartlinks | BioMérieux SA | News | Health | Finance | Security Markets | Security Markets | Company News | Securities Issuers | Medical Supplies and Equipment Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Tradegate Exchange | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | Equiduct | Euronext Block MTF | Hannover Stock Exchange | Turquoise
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact